Clinton Scott Shultz

Follow

Person

Maplewood, NJ, US

People

Patents Grantslast 30 patents

Information Patent Grant
Synthetic pathway to belzutifan and crystalline phases of synthetic...
- Patent number 11,827,614
- Issue date Nov 28, 2023
- Merck Sharp & Dohme LLC
- Stephen M. Dalby
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystal forms of a HCV protease inhibitor
- Patent number 9,242,917
- Issue date Jan 26, 2016
- Merck Sharp & Dohme Limited
- Gregory L Beutner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
- Patent number 7,235,671
- Issue date Jun 26, 2007
- Merck & Co. Inc.
- Kevin Seibert
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
NOVEL SYNTHETIC PATHWAY TO BELZUTIFAN AND CRYSTALLINE PHASES OF SYN...
- Publication number 20220388974
- Publication date Dec 8, 2022
- Merck Sharp & Dohme LLC
- Stephen M. Dalby
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID PRODRUG FORMS OF 2'-CHLORO-2'-METHYL URIDINE FOR HCV
- Publication number 20170066795
- Publication date Mar 9, 2017
- Idenix Pharmaceuticals LLC
- John Zoltan Sulliva-Bolyai
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRYSTAL FORMS OF A HCV PROTEASE INHIBITOR
- Publication number 20140206605
- Publication date Jul 24, 2014
- Gregory L. Beutner
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Process for preparing 3-chloromethyl-1,2,4-triazolin-5-one
- Publication number 20060052355
- Publication date Mar 9, 2006
- Kevin Seibert
- C07 - ORGANIC CHEMISTRY